z-logo
open-access-imgOpen Access
FOXG1 Dose in Brain Development
Author(s) -
Nuwan C. Hettige,
Carl Ernst
Publication year - 2019
Publication title -
frontiers in pediatrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.96
H-Index - 36
ISSN - 2296-2360
DOI - 10.3389/fped.2019.00482
Subject(s) - medicine , brain development , intensive care medicine , neuroscience , psychology
Brain development is a highly regulated process that involves the precise spatio-temporal activation of cell signaling cues. Transcription factors play an integral role in this process by relaying information from external signaling cues to the genome. The transcription factor Forkhead box G1 ( FOXG1 ) is expressed in the developing nervous system with a critical role in forebrain development. Altered dosage of FOXG1 due to deletions, duplications, or functional gain- or loss-of-function mutations, leads to a complex array of cellular effects with important consequences for human disease including neurodevelopmental disorders. Here, we review studies in multiple species and cell models where FOXG1 dose is altered. We argue against a linear, symmetrical relationship between FOXG1 dosage states, although FOXG1 levels at the right time and place need to be carefully regulated. Neurodevelopmental disease states caused by mutations in FOXG1 may therefore be regulated through different mechanisms.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom